| Literature DB >> 34447441 |
Ewa Sadowska-Krępa1, Sebastian Bańkowski1, Agnieszka Kargul2, Janusz Iskra3.
Abstract
BACKGROUND: The effectiveness of sport training programs should be assessed regularly against biochemical indices. This study assesses changes in the antioxidant status indices in American football players (AF) and soccer players (SP) over a training macrocycle.Entities:
Keywords: American football; Antioxidant enzymes; Lipid peroxidation; Non-enzymatic antioxidants; Training
Year: 2021 PMID: 34447441 PMCID: PMC8374684 DOI: 10.1016/j.jesf.2021.08.001
Source DB: PubMed Journal: J Exerc Sci Fit ISSN: 1728-869X Impact factor: 3.103
The basic characteristics of participants.
| Variable | AF (n = 11) | SP (n = 11) |
|---|---|---|
| Age, years | 24.0 ± 3.7 | 26.5 ± 3.8 |
| Height, cm | 183.7 ± 10.3 | 182.7 ± 5.4 |
| Body mass, kg | 98.2 ± 15.5 | 81.1 ± 5.4 |
| VO2max, ml/kg/min | 52.4 ± 3.7 | 56.7 ± 4.3 |
Characteristics of training programs for American football players and soccer players.
| Sport | Period | |||
|---|---|---|---|---|
| Preparation | Competition | Transition | ||
| General | Special | |||
| American football | - maximum strength building, | - endurance training (gym and playing field) | - strength training with reduced volume | - lower intensity exercises |
| Soccer | - motor skills | - tactical and technical training | - special exercises and high-intensity aerobic exercises, speed exercises, and speed-endurance exercises | - lower intensity exercises |
The indices of participants’ blood antioxidant status by period of the training macrocycle.
| Variable | Period | AF (n = 11) | SP (n = 11) | A mixed ANOVA | Eta squared |
|---|---|---|---|---|---|
| SOD, U/gHb | PP | 1270.61 ± 174.42 | 1161.10 ± 264.50 | GE: F1,20 = 3.39, p = 0.08 | η2 = 0.15 |
| CP | 1426.30 ± 282.49 | 1545.00 ± 413.53∗ | PE: F2,40 = 9.01, p < 0.001 | η2 = 0.31 | |
| TP | 1346.86 ± 185.49 | 988.15 ± 182.51##† | INT: F2,40 = 4.37, p < 0.05 | η2 = 0.18 | |
| CAT, U/gHb | PP | 195.45 ± 26.42 | 188.44 ± 44.21 | GE: F1,20 = 1.03, p = 0.32 | η2 = 0.05 |
| CP | 199.49 ± 19.42 | 204.55 ± 35.43 | PE: F2,40 = 6.30, p < 0.05 | η2 = 0.24 | |
| TP | 195.11 ± 13.37 | 163.55 ± 36.60##†† | INT: F2,40 = 4.24, p < 0.05 | η2 = 0.18 | |
| GPx, U/gHb | PP | 56.60 ± 6.56 | 44.69 ± 14.29 | GE: F1,20 = 3.98, p = 0.06 | η2 = 0.17 |
| CP | 54.89 ± 8.72 | 42.22 ± 12.07† | PE: F2,40 = 8.73, p < 0.001 | η2 = 0.30 | |
| TP | 59.08 ± 8.99 | 60.35 ± 17.49∗∗## | INT: F2,40 = 3.81, p < 0.05 | η2 = 0.16 | |
| GSH, μg/mgHb | PP | 2.35 ± 0.35 | 2.06 ± 0.12 | GE: F1,20 = 0.90, p = 0.36 | η2 = 0.04 |
| CP | 2.70 ± 0.29 | 2.94 ± 0.36∗∗ | PE: F2,40 = 29.82, p < 0.0001 | η2 = 0.60 | |
| TP | 2.56 ± 0.37 | 2.89 ± 0.35∗∗ | INT: F2,40 = 8.36, p < 0.001 | η2 = 0.29 | |
| UA, mg/dl | PP | 5.62 ± 0.78 | 4.28 ± 1.67 | GE: F1,20 = 0.63, p = 0.44 | η2 = 0.03 |
| CP | 5.91 ± 0.62 | 5.83 ± 1.65 | PE: F2,40 = 18.73, p < 0.0001 | η2 = 0.48 | |
| TP | 6.29 ± 1.21 | 6.85 ± 1.93## | INT: F2,40 = 6.42, p < 0.01 | η2 = 0.24 |
SOD – superoxide dismutase, CAT – catalase, GPx – glutathione peroxidase, GSH – glutathione, UA – uric acid, PP – preparatory period, CP – competition period, TP – transition period, GE – group effect, PE – period effect, INT – group × period interaction effect.
Values are presented as mean (SD). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.0001 – significantly different vs. PP; ##p < 0.01 – significantly different vs. CP; †p < 0.05, ††p < 0.01 – significantly different between AF and SP.
The indices of participants’ muscle damage by period of the training macrocycle.
| Variable | Period | AF (n = 11) | SP (n = 11) | A mixed ANOVA | Eta squared |
|---|---|---|---|---|---|
| MDA, μmol/l | PP | 6.28 ± 1.02 | 4.80 ± 0,70† | GE: F1,20 = 16.57, p < 0.001 | η2 = 0.45 |
| CP | 6.26 ± 1.28 | 4.70 ± 0.78† | PE: F2,40 = 4.81, p < 0.01 | η2 = 0.20 | |
| TP | 6.89 ± 1.85 | 5.91 ± 1.09 | INT: F2,40 = 0.58, p = 0.56 | η2 = 0.03 | |
| CK, U/l | PP | 306.92 ± 95.37 | 263.94 ± 122.76 | GE: F1,20 = 0.67, p = 0.42 | η2 = 0.03 |
| CP | 271.13 ± 102.17 | 293.89 ± 78.73 | PE: F2,40 = 1.95, p = 0.16 | η2 = 0.09 | |
| TP | 293.11 ± 118.21 | 224.11 ± 126.37 | INT: F2,40 = 0.58, p = 0.57 | η2 = 0.03 | |
| LDH, U/l | PP | 401.78 ± 67.89 | 289.99 ± 67.54† | GE: F1,20 = 21.20, p < 0.0001 | η2 = 0.51 |
| CP | 382.60 ± 63.65 | 276.14 ± 77.22† | PE: F2,40 = 10.42, p < 0.001 | η2 = 0.34 | |
| TP | 430.52 ± 48.29 | 355.20 ± 5.53∗# | INT: F2,40 = 0.93, p = 0.40 | η2 = 0.04 |
MDA – malondialdehyde, CK – creatine kinase, LDH – lactate dehydrogenase, PP – preparatory period, CP – competition period, TP – transition period, GE – group effect, PE – period effect, INT – group × period interaction effect.
The values in the table represent means (SD). ∗p < 0.05 – significantly different vs. PP; #p < 0.05 – significantly different vs. CP; †p < 0.05 – significantly different between AF and SP.